Aurobindo Pharma Ltd.’s first-quarter profit rose, in-line with analysts’ estimates.The Hyderabad-based bulk and generic drug maker’s net profit rose 10% year-on-year to Rs 571 crore in the quarter ended June, according to an exchange filing. That compares with the Rs 557-crore consensus estimate of analysts tracked by Bloomberg.Sequentially, it rose 13%.
The IDF Spokesperson announced Wednesday morning that there had been an historic event in the skies over Tehran. An...
Gen X is expected to consume over $500 billion worth of goods and services by FY30 fuelling demand for various...
For finance leaders at large retailers and brands, excess and returned inventory can pose a significant drag on working capital...
The Government of India is working on a plan to bring its separate tax and financial reporting regimes under a...
The consumer discretionary space continues to reveal a mixed performance across segments, driven by gold prices, festive shifts, and evolving...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
